aparoscopic versus open distal pancreatectomy for symptomatic benign, premalignant and malignant disease - LEOPARD trial

Academisch Medisch Centrum0 个研究点目标入组 102 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•* Age equal or above 18 years;
•* Indication for elective distal pancreatectomy (+ / - splenectomy) because of proven or suspected symptomatic benign, premalignant or malignant disease of the distal pancreas (as defined in section 4.4);
•* Tumor meeting the Yonsei criteria33:
•* Fit to undergo distal pancreatectomy according to the surgeon and anaesthetist.

•* Tumor or cyst larger than 8 cm;
•* Distal pancreatectomy is not the sole procedure, so when a surgical intervention (resection / ablation) of other organs besides the distal pancreas or spleen is performed (minor procedures, such as cholecystectomy, are allowed);
•* Chronic pancreatitis (according to the M-ANNHEIM criteria, see Appendix 2 for detailed definition);
•* Previous radiotherapy for pancreatic cancer;
•* Pregnancy;
•* Participation in another study with interference of study outcomes.

发起方